Article

Medicare to cover PDT for select AMD patients

Washington, DC-The Centers for Medicare and Medicaid Services has begun to cover ocular photodynamic therapy (PDT) with verteporfin to treat select patients with subfoveal occult, but no classic choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD) and subfoveal minimally classic CNV.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
Ocular Therapeutix to present at Clinical Trials at the Summit 2025
June 18th 2025

Ocular Therapeutix to present at Clinical Trials at the Summit 2025

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Eyestem completes phase 1 study of Eyecyte-RPE in patients with geographic atrophy
June 18th 2025

Eyestem completes phase 1 study of Eyecyte-RPE in patients with geographic atrophy

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

(Image credit: AdobeStock/Sam Efendi) Analyzing FLIO data from the AI-READI project with Aaron Y. Lee, MD, MSCI
June 17th 2025

Analyzing FLIO data from the AI-READI project with Aaron Y. Lee, MD, MSCI

(Image credit: AdobeStock/Nadiia) Mount Sinai’s NYEE unveils Center for Refractive Solutions
June 17th 2025

Mount Sinai’s NYEE unveils Center for Refractive Solutions

© 2025 MJH Life Sciences

All rights reserved.